MARTINA, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 1.906
EU - Europa 733
AS - Asia 157
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.803
Nazione #
US - Stati Uniti d'America 1.897
IE - Irlanda 178
IT - Italia 147
SE - Svezia 134
UA - Ucraina 85
SG - Singapore 53
DE - Germania 44
CN - Cina 35
GB - Regno Unito 35
BE - Belgio 33
FR - Francia 31
DK - Danimarca 26
TR - Turchia 25
IN - India 20
FI - Finlandia 16
KR - Corea 15
CA - Canada 9
JP - Giappone 6
RO - Romania 3
CI - Costa d'Avorio 2
GE - Georgia 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
KG - Kirghizistan 1
PL - Polonia 1
SC - Seychelles 1
Totale 2.803
Città #
Chandler 367
Des Moines 322
Dublin 169
Ashburn 126
Fairfield 117
Jacksonville 101
New York 100
Wilmington 57
Lawrence 53
Princeton 53
Woodbridge 53
Boardman 52
Seattle 48
Houston 39
Cambridge 37
Centro 35
San Mateo 34
Brussels 33
Turin 24
San Diego 22
Washington 18
Redmond 14
London 13
Pune 13
Ann Arbor 11
Guangzhou 9
Toronto 9
Norwalk 7
Beijing 5
Kolkata 5
Boydton 4
Creazzo 4
Helsinki 4
Hounslow 4
Lunano 4
Bucharest 3
Chiswick 3
Civitanova Marche 3
Florence 3
Jesi 3
Marche 3
New Bedfont 3
Trieste 3
Abidjan 2
Ancona 2
Andover 2
Hangzhou 2
Hanover 2
Kilburn 2
Matera 2
Menlo Park 2
North Augusta 2
Parma 2
Prescot 2
Rimini 2
Rome 2
San Casciano In Val Di Pesa 2
Shanghai 2
Tbilisi 2
Tokyo 2
Wandsworth 2
Acquaviva Picena 1
Acton 1
Adana 1
Ascoli Piceno 1
Auburn 1
Bellaria-Igea Marina 1
Bishkek 1
Brisbane 1
Casalecchio di Reno 1
Genova 1
Laurel 1
Mahé 1
Monsampolo del Tronto 1
Montesilvano 1
Morrovalle 1
Naples 1
Novara 1
Osimo 1
Redwood City 1
Riva 1
Seelze 1
Somerville 1
Talca 1
Urbino 1
Warsaw 1
Totale 2.051
Nome #
Adalimumab modulates angiogenesis in psoriatic skin 86
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 82
Hidradenitis suppurativa: How to treat with BoNT-A 82
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 81
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 77
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 77
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 75
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 74
Photoprotection and photodermatitis: a case 71
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 70
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 70
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 68
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? 67
Skin Involvement in SARS-CoV-2 Infection: Case Series 66
"BOTULINUM TOXIN IN DERMATOLOGY: A CLINICAL OVERVIEW" 65
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 62
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 61
It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients 61
Safety update of etanercept treatment for moderate to severe plaque psoriasis 60
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 60
Role of small intestinal bacterial overgrowth and helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis 58
Botulinum Toxin Off-Label Use in Dermatology: A Review 58
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 58
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 56
Modern electronic devices: An increasingly common cause of skin disorders in consumers 56
Primary cutaneous large cell lymphoma CD30+: a case-based review 55
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 54
Myroxylon pereirae (balsam of Peru): Still worth testing? 54
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 54
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 53
VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should now 51
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 50
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 47
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage 45
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 45
Iperidrosi focale: novità terapeutiche 42
Topical application of fumaric acid esters improves appearance of nail psoriasis 42
Omalizumab in Chronic Urticaria: An Italian Survey. 40
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 40
Acral Leukoderma: Is It Always Vitiligo? 39
Asymptomatic pigmentation of the skin in a child: babywipes, once again 35
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 34
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 33
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 33
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 33
Saliva and Oral Diseases 32
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 31
Contact allergy to hydrocortisone 21-acetate in Italy: A SIDAPA multicenter study 30
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 28
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 28
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 26
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 24
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 19
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 16
Mesenchymal Stem Cells and Psoriasis: Systematic Review 16
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 15
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 13
Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study 13
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 6
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going 5
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 5
The pharmacological treatment and management of hyperhidrosis 4
Totale 2.891
Categoria #
all - tutte 16.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 3 0 1 1 1
2019/2020141 7 0 16 6 23 1 19 8 21 10 3 27
2020/2021420 32 33 50 11 36 21 34 31 32 35 68 37
2021/2022409 8 56 12 2 35 15 9 31 23 12 121 85
2022/20231.204 78 119 63 97 52 419 1 49 218 6 79 23
2023/2024551 95 19 60 69 110 172 10 16 0 0 0 0
Totale 2.891